Stephen Fawell insider trades
Open-market stock purchases and sales by Stephen Fawell, Director at C4 Therapeutics, Inc, from SEC Form 4 filings since Aug 29, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 24, 2026 | CCCC C4 Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- CCCC C4 Therapeutics, Inc: other filings, last Jun 24, 2026